KOBAYASHI PHARM
There is no Profile data available for KOY.MU.
Market Cap & Net Worth: KOBAYASHI PHARM (KOY)
KOBAYASHI PHARM (MU:KOY) has a market capitalization of $298.01K (€290.32K) as of March 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #38584 globally and #5280 in its home market, demonstrating a -1.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying KOBAYASHI PHARM's stock price €30.40 by its total outstanding shares 9550 (9.55K).
KOBAYASHI PHARM Market Cap History: 2015 to 2026
KOBAYASHI PHARM's market capitalization history from 2015 to 2026. Data shows growth from $19.56 Million to $298.01K (80.55% CAGR).
KOBAYASHI PHARM Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how KOBAYASHI PHARM's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
KOBAYASHI PHARM's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
KOBAYASHI PHARM's market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $10.64K | $156.76 Billion | $15.86 Billion | 0.00x | 0.00x |
| 2018 | $20.14K | $167.48 Billion | $18.02 Billion | 0.00x | 0.00x |
| 2019 | $116.08K | $168.05 Billion | $19.14 Billion | 0.00x | 0.00x |
| 2020 | $455.35K | $150.51 Billion | $19.20 Billion | 0.00x | 0.00x |
| 2021 | $671.49K | $155.25 Billion | $19.71 Billion | 0.00x | 0.00x |
| 2022 | $622.48K | $166.26 Billion | $20.02 Billion | 0.00x | 0.00x |
| 2023 | $413.68K | $173.46 Billion | $20.34 Billion | 0.00x | 0.00x |
| 2024 | $360.74K | $165.60 Billion | $10.07 Billion | 0.00x | 0.00x |
Competitor Companies of KOY by Market Capitalization
Companies near KOBAYASHI PHARM in the global market cap rankings as of March 19, 2026.
Key companies related to KOBAYASHI PHARM by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2400 globally with a market cap of $6.13 Billion USD ( €5.98 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2412 globally with a market cap of $6.09 Billion USD ( €5.94 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2400 | BERKSHIRE HATH-A | BE:BRH | $6.13 Billion | €634500.00 |
| #2412 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.09 Billion | €638000.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
KOBAYASHI PHARM Historical Marketcap From 2015 to 2026
Between 2015 and today, KOBAYASHI PHARM's market cap moved from $19.56 Million to $ 298.01K, with a yearly change of 80.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €298.01K | +2.70% |
| 2025 | €290.16K | -19.57% |
| 2024 | €360.74K | -12.80% |
| 2023 | €413.68K | -33.54% |
| 2022 | €622.48K | -7.30% |
| 2021 | €671.49K | +47.47% |
| 2020 | €455.35K | +292.26% |
| 2019 | €116.08K | +476.47% |
| 2018 | €20.14K | +89.29% |
| 2017 | €10.64K | +528.01% |
| 2016 | €1.69K | -99.99% |
| 2015 | €19.56 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of KOBAYASHI PHARM was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $298.01K USD |
| MoneyControl | $298.01K USD |
| MarketWatch | $298.01K USD |
| marketcap.company | $298.01K USD |
| Reuters | $298.01K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.